Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
45.49
-0.05 (-0.11%)
At close: Apr 29, 2026
33.82%
Market Cap 7.60B
Revenue (ttm) 838.12M
Net Income (ttm) 165.57M
Shares Out 167.18M
EPS (ttm) 0.99
PE Ratio 44.85
Forward PE 29.12
Dividend 0.57 (1.25%)
Ex-Dividend Date n/a
Volume 2,701,535
Average Volume 5,207,117
Open 45.01
Previous Close 45.54
Day's Range 44.25 - 45.55
52-Week Range 33.14 - 71.49
Beta 0.84
RSI 45.85
Earnings Date Apr 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2025, Acrobiosystems's revenue was 838.12 million, an increase of 29.94% compared to the previous year's 645.02 million. Earnings were 165.57 million, an increase of 33.70%.

Financial Statements

News

There is no news available yet.